Canadian Society of Surgical Oncology Nineteenth Annual Scientific MeetingWhat provider volume is appropriate for gastric cancer resection? Results of a RAND/UCLA expert panelSelf-renewal as a therapeutic target in human colorectal cancerA novel hepatic parenchymal preserving technique in the management of neuroendocrine tumour liver metastases: a feasible approachInflammatory markers predict survival in liver metastases from colorectal cancerResection of multisite metastases from colorectal cancer: feasibility and interim results of a multicentre prospective phase II studyIs fine-needle aspiration cytology in symptomatic breast lesions still an important diagnostic modality?The effect of surgery on recurrence and survival of young women with breast cancerSurvival and selection criteria for cytoreductive surgery in patients with peritoneal carcinomatosis from colorectal cancer: results from a prospective Canadian cohortHow often do level 3 nodes bear melanoma metastases, and does it affect patient outcomes?Predicting outcomes of thyroid cancerLong-term outcomes of stenting as a bridge to surgery for acute left-sided malignant colonic obstruction
Natalie G. Coburn(Malaysian Cocoa Board), Barbara Loftus(Tallaght University Hospital), Ashlie Nadler(Toronto General Hospital), Lawrence Paszat(University of Toronto), Cynthia Heffron(Tallaght University Hospital), Thomas W. Davis(PTC Therapeutics (United States)), Young‐Choon Moon(PTC Therapeutics (United States)), Alyson Mahar(Malaysian Cocoa Board), Matthew Dixon(Rush University Medical Center), Carol J. Swallow(University Health Network), Myles Smith(Royal Marsden NHS Foundation Trust), Peter van Galen(Broad Institute), Elijah Dixon(University of Calgary), Roberta Cardoso(Sunnybrook Health Science Centre), Sean P. Cleary(University Health Network), Ramil Baiazitov(PTC Therapeutics (United States)), Lucy Helyer(Dalhousie University), Wu Du(PTC Therapeutics (United States)), Laurent Milot(Sunnybrook Health Science Centre), Steven Gallinger(Mount Sinai Hospital), Derek Leuger(University of Calgary), Liangxian Cao(PTC Therapeutics (United States)), Carolyn Nessim(University of Ottawa), Nadiya Sydorenko(PTC Therapeutics (United States)), Trevor D. Hamilton(Vancouver General Hospital), Pamela Hebbard(University of Manitoba), Oliver F. Bathe(University of Calgary), Fayez A. Quereshy(University Health Network), Eva Szentgyörgyi(University of Toronto), Kalyani Pathak(Dibrugarh University), Catherine O′Brien(University Health Network), Karen Kopachuk(University of Calgary), Moisés Cukier(Toronto General Hospital), John E. Dick(University of Toronto), Simron Singh(Sunnybrook Health Science Centre), Robin S. McLeod(University of Toronto), Paul D. Greig(University of Toronto), Carol-Anne Moulton(University Health Network), Calvin Law(Sunnybrook Health Science Centre), Jane Rothwell(Tallaght University Hospital), Yarrow J. McConnell(Alberta Health Services), Francis Sutherland(University of Calgary), Antonija Kreso(Ontario Institute for Cancer Research), Alice C. Wei(Université Paris Cité), Katharine S. Devitt(University Health Network), Rajini Seevaratnam(Sunnybrook Health Science Centre)
Cited by 0
Related Papers
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.9k
Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS)
|Surgery|2011|2.3k